(MENAFN- Straits Research)
Bioinformatics Market Size, Share & Growth Analysis
The global bioinformatics market size was valued at USD 20.34 billion in 2025 and is projected to grow from USD 23.13 billion in 2026 to USD 64.59 billion by 2034, registering a CAGR of 13.7% during the forecast period from 2026 to 2034. North America dominated the bioinformatics market with a market share of 39.5% in 2025.
The field of bioinformatics combines biology and information technology. It connects biological data with information collection, distribution, and evaluation tools to serve numerous aspects of scientific research, such as biomedicine. It utilizes several software tools for database construction, data management, warehousing, and mining. Data mining yields scientific discoveries applied to the study of genetics and genomes.
Combining computer programming, big data, and biology, bioinformatics enables scientists to comprehend and detect patterns in biological data. It is valuable in studying genomes and DNA sequencing since it allows scientists to arrange vast amounts of data. There are a variety of bioinformatics tools on the market. These are protein functional and analysis tools, homology and similarity tools, sequence analysis tools, and other tools.
Bioinformatics Market Key Takeaways
Global Market Size & Growth
2025 Market Size: USD 20.34 Billion
2026 Market Size: USD 23.13 Billion
2034 Projected Market Size: USD 64.59 Billion
Forecast Period: 2026–2034
Base Year: 2025
Market CAGR (2026–2034): 13.7%
Regional Insights
Largest Regional Market (2025): North America
North America Market Share (2025): 39.5%
Fastest-Growing Region: Europe
Europe CAGR (2026–2034): 14.6%
Segment Insights
By Technology & Service
Leading Segment: Bioinformatics Platforms
Market Share in 2025: 42.3%
By Application
Fastest-growing segment: Genomics
CAGR (2026–2034): 14.6%
By Sector
Leading Segment: Medical Bioinformatics
Market Share in 2025: 46.2%
Download a Free Sample To learn more about this report,
Bioinformatics Market Trends
Growing Integration of AI, Multi-Omics, and Long-Read Sequencing
The bioinformatics market is shifting toward artificial intelligence, cloud-based workflows, and combined analysis of genomic, transcriptomic, proteomic, and clinical data. Researchers increasingly use machine learning to classify genetic variants, predict protein structures, identify biomarkers, and prioritize potential drug targets. Long-read sequencing is creating demand for tools that can process complete genomes, complex structural variants, and previously unresolved regions. At the same time, human pangenome resources are reducing dependence on a single reference sequence and improving analysis across diverse populations. Open scientific databases remain central to research, while secure computing environments are becoming more important for handling sensitive patient information and supporting reproducible clinical studies.
In March 2026, the U.S. Human Genome Reference Program advanced work on a pangenome containing high-quality assemblies from hundreds of genetically diverse individuals.
Bioinformatics Market Dynamics
Market Drivers
Rapid Growth of Genomic Data and Precision Medicine Drives Demand
Falling sequencing costs and wider use of molecular testing are producing large volumes of biological data that cannot be interpreted manually. Bioinformatics platforms help researchers align sequences, detect variants, compare gene expression, model proteins, and connect molecular findings with disease information. Precision oncology, rare-disease diagnosis, drug discovery, agricultural genomics, and infectious-disease surveillance are major demand areas. Hospitals and laboratories increasingly need automated pipelines that convert raw sequencing output into clear and traceable results. Public research programs also require tools for storing and sharing information across institutions. These developments are supporting demand for analysis software, curated databases, cloud computing, visualization tools, and specialized bioinformatics services.
In May 2025, Global public-health experts emphasized that pathogen genomic surveillance supports the detection of emerging threats and tracking of disease transmission and evolution.
Market Restraints
High Infrastructure Costs and Skills Shortages Limit Adoption
Bioinformatics projects require powerful computing systems, secure data storage, specialized software, and professionals who understand biology, statistics, programming, and clinical interpretation. These requirements can be expensive for smaller laboratories and institutions in developing regions. Large sequencing files also raise ongoing costs for transfer, backup, cloud processing, and long-term retention. Human genomic data creates strict privacy and consent obligations because complete anonymization can be difficult. Integration is another restraint, as laboratories often use different data formats, reference sequences, and analysis pipelines. Limited internet capacity and unreliable laboratory infrastructure can further restrict cloud-based workflows. These barriers create unequal access to advanced genomic analysis and reduce practical adoption.
In June 2025, Sierra Leone had genomically characterized only 108, or about 2.5%, of more than 4,400 confirmed mpox cases, demonstrating major analysis-capacity gaps.
Market Opportunities
Pathogen Surveillance and Population Genomics Offer Strong Potential
Expanding pathogen surveillance creates major opportunities for bioinformatics tools that identify variants, trace outbreaks, monitor antimicrobial resistance, and combine genomic findings with epidemiological data. Wastewater sequencing can widen surveillance by detecting pathogens circulating in communities before conventional reporting provides a complete picture. Population genomics offers another opportunity because more representative reference datasets can improve variant detection and reduce ancestry-related bias. Developing countries need affordable pipelines, regional data centers, workforce training, and secure platforms that can operate with limited computing resources. Additional growth potential exists in agricultural breeding, microbiome research, rare-disease interpretation, and AI-supported drug discovery. Open standards and interoperable systems can help institutions share data more efficiently.
In June 2025, A global pathogen-surveillance network launched a dedicated community focused on advancing genomics for wastewater and environmental monitoring.
Market Challenges
Data Quality, Reproducibility, and Algorithmic Bias Remain Critical
Producing trustworthy results remains difficult because conclusions can change with sample quality, reference databases, software versions, filtering rules, and statistical assumptions. AI models may reproduce bias when training datasets underrepresent certain populations, diseases, or geographical regions. Biological databases also contain incomplete, duplicated, or incorrectly annotated records that require continuous expert curation. Reproducibility becomes challenging when pipelines are not fully documented or when proprietary algorithms cannot be independently examined. Clinical applications require additional validation because an incorrect variant classification may affect diagnosis or treatment decisions. Bioinformatics providers must therefore maintain transparent workflows, version control, cybersecurity, standardized formats, and clear quality checks while keeping rapidly changing datasets and tools current.
In October 2025, A major international protein database introduced a revised reference-proteome selection workflow and began removing records from taxonomically unclassified species to improve data quality.
Bioinformatics Market Segmentation Analysis
By Technology & Service
Bioinformatics Platforms is the leading segment, accounting for 42.3% market share, with a market value of USD 8.6 billion and a CAGR of 13.6%. The segment includes Sequence Analysis Platforms, Sequence Alignment Platforms, Sequence Manipulation Platforms, Structural Analysis Platforms, and Others. Among these, sequence analysis platforms hold a strong position due to their use in genomic and molecular research. The growing volume of biological data, increasing sequencing activity, and rising demand for computational analysis are supporting platform adoption. These solutions are increasingly used in genomics, drug discovery, healthcare research, and biotechnology applications.
Request Customization to receive a tailored report.
By Application
Genomics is the leading application segment, holding 27.5% market share, with a market value of USD 5.59 billion and a CAGR of 14.6%. The application landscape also includes Metabolomics, Molecular Phylogenetics, Transcriptomics, Proteomics, Chemoinformatics & Drug Design, and Others. Genomics remains prominent because of the increasing use of sequencing and computational analysis in genetic research, disease studies, precision medicine, and drug development. At the same time, transcriptomics, proteomics, and chemoinformatics are expanding the use of bioinformatics across different areas of life sciences research, supporting broader adoption of computational approaches.
By Sector
Medical Bioinformatics is the leading sector, accounting for 46.2% market share, with a market value of USD 9.4 billion and a CAGR of 14.3%. Other sectors include Animal Bioinformatics, Agriculture Bioinformatics, Academics, and Others. Medical bioinformatics benefits from growing applications in genomic analysis, disease research, biomarker discovery, personalized medicine, and therapeutic development. Meanwhile, animal and agriculture bioinformatics support genetic research, breeding, and biological studies, while academic institutions use bioinformatics for education and scientific research. These diverse applications demonstrate the expanding role of bioinformatics across healthcare, agriculture, animal sciences, and academic research.
Speak to an Analyst to discuss market opportunities.
Bioinformatics Market Regional Outlook
North America Bioinformatics Market Analysis
North America is the dominant region in the bioinformatics market, holding the highest market share of 39.5%, with a market value of USD 8.03 billion and a CAGR of 12.8%. The region's strong position reflects its established research ecosystem, advanced healthcare infrastructure, and widespread use of computational technologies in life sciences. Strong demand for genomic research, drug discovery, and biological data analysis supports regional development. Continued investment in advanced technologies and data-driven research is expected to maintain North America's leading position in the global bioinformatics market.
United States Bioinformatics Market Insights
The United States plays an important role in the regional bioinformatics market due to its strong life sciences ecosystem and advanced research capabilities. The country has a broad network of universities, research institutions, pharmaceutical companies, biotechnology firms, and healthcare organizations that use bioinformatics across multiple applications. Genomics, precision medicine, drug discovery, and computational biology are important areas of activity. Collaboration between academic researchers, technology companies, and life sciences organizations is also supporting innovation and the development of new computational approaches for biological research and healthcare.
Canada Bioinformatics Market Insights
Canada is contributing to the growth of the regional bioinformatics market through its strong academic research base and expanding biotechnology ecosystem. Universities, research centers, healthcare organizations, and life sciences companies are increasingly using computational methods to study genomic and biological data. Bioinformatics supports research in areas such as genomics, disease investigation, drug development, and molecular biology. The country's collaborative research environment encourages partnerships between scientific institutions and industry participants. Continued development of research infrastructure and computational expertise is helping Canada strengthen its role in the broader life sciences landscape.
Unlock Regional Insights to access country-level data, & regional trends.
Europe Bioinformatics Market Analysis
Europe is the fastest-growing region in the bioinformatics market, recording the highest CAGR of 14.6%, while accounting for a market share of 27.2% and a market value of USD 5.53 billion. The region benefits from strong research capabilities, established healthcare systems, and increasing collaboration across the life sciences sector. Growing adoption of genomics, computational biology, and data-driven research is supporting demand for bioinformatics solutions. The region's emphasis on scientific collaboration and innovation is creating a favorable environment for continued bioinformatics development and adoption.
Germany Bioinformatics Market Insights
Germany has a strong foundation for bioinformatics development, supported by its advanced scientific research infrastructure and well-established biotechnology and pharmaceutical sectors. Research institutions and universities use computational tools to support genomics, molecular biology, drug discovery, and disease research. The country's focus on scientific innovation encourages collaboration between academic organizations, healthcare institutions, and industry participants. Bioinformatics is also becoming increasingly important for handling complex biological datasets and supporting data-driven research. Germany's strong industrial base provides additional opportunities for the integration of computational biology into pharmaceutical development and biotechnology.
United Kingdom Bioinformatics Market Insights
The United Kingdom has a well-developed bioinformatics ecosystem supported by leading universities, research organizations, healthcare institutions, and biotechnology companies. The country has strong capabilities in genomics, computational biology, and biological data management, creating a favorable environment for innovation. Bioinformatics is widely relevant to areas such as disease research, drug discovery, personalized healthcare, and genomic analysis. Collaboration between public research institutions and private organizations supports the development and adoption of advanced computational tools. The UK's emphasis on scientific research and data-driven healthcare also encourages the use of bioinformatics to interpret complex biological information.
Asia Pacific Bioinformatics Market Analysis
Asia Pacific represents a significant part of the bioinformatics market, with a market share of 22.4%, a market value of USD 4.56 billion, and a CAGR of 13.9%. The region is benefiting from growing investments in biotechnology, genomics, healthcare research, and digital technologies. Increasing research activity and the expansion of life sciences capabilities are creating demand for computational tools that can manage and interpret biological data. The region's large research community and expanding biotechnology sector provide opportunities for bioinformatics adoption. As organizations increasingly use genomic and molecular information for scientific research and healthcare applications, the region is expected to remain an important contributor to global market development.
Japan Bioinformatics Market Insights
Japan has a well-established scientific and technological environment that supports the adoption of bioinformatics across healthcare and life sciences research. Universities, research institutions, pharmaceutical companies, and biotechnology organizations use computational approaches for genomics, molecular research, and drug development. The country's strong capabilities in advanced technology and scientific research provide a solid foundation for integrating bioinformatics into complex research workflows. Increasing interest in personalized medicine and biological data analysis is also supporting demand for computational solutions. Collaboration between academic institutions and industry participants helps encourage innovation and knowledge sharing, strengthening Japan's role in the regional bioinformatics ecosystem.
China Bioinformatics Market Insights
China is developing a growing bioinformatics ecosystem supported by expanding biotechnology research, healthcare investment, and scientific infrastructure. Research institutions and life sciences companies are increasingly using computational tools to analyze genomic and biological datasets. Bioinformatics is relevant to areas such as genetic research, drug discovery, disease studies, and agricultural biotechnology. The country's expanding research capabilities and growing focus on technological innovation are supporting wider adoption of computational biology. Increasing collaboration between universities, research organizations, and biotechnology companies is also helping strengthen the development of bioinformatics solutions.
Middle East and Africa Bioinformatics Market Analysis
The Middle East and Africa region holds a market share of 4.8%, with a market value of USD 0.98 billion and a CAGR of 10.7%. The region is gradually developing its bioinformatics capabilities through increasing interest in healthcare innovation, genomics, biotechnology, and digital research. Investments in research infrastructure and technology are helping organizations adopt computational approaches for biological data analysis. Bioinformatics can support disease research, genomic studies, and healthcare applications where advanced data interpretation is required. Continued development of scientific infrastructure, research partnerships, and biotechnology capabilities is creating opportunities for broader adoption of bioinformatics solutions.
UAE (United Arab Emirates) Bioinformatics Market Insights
The UAE is emerging as an important hub for healthcare innovation, biotechnology, and advanced scientific research in the Middle East. The country is increasingly focusing on modern healthcare technologies and data-driven approaches that can support research and clinical development. Bioinformatics can contribute to genomics, precision medicine, disease research, and the interpretation of complex biological information. Collaboration between healthcare institutions, research organizations, universities, and technology companies is helping create opportunities for computational biology applications. The UAE's focus on building a knowledge-based economy and strengthening its life sciences capabilities also provides a supportive environment for the development of bioinformatics research and related technologies.
Latin America Bioinformatics Market Analysis
Latin America accounts for a market share of 6.1%, with a market value of USD 1.24 billion and a CAGR of 11.4%. The region is gradually expanding its use of bioinformatics as research institutions, universities, healthcare organizations, and biotechnology companies increase their focus on genomic and biological data. Bioinformatics can support applications including disease research, genomics, agricultural biotechnology, and drug development. The development of scientific infrastructure and greater collaboration among research organizations are helping improve access to computational tools. As regional life sciences capabilities continue to develop, bioinformatics can play a growing role in supporting biological research and data-driven innovation across Latin America.
Brazil Bioinformatics Market Insights
Brazil represents an important bioinformatics market within Latin America, supported by its large scientific community, universities, research institutions, and growing biotechnology sector. The country has opportunities to apply computational biology across healthcare, genomics, agricultural research, and biodiversity studies. Researchers can use bioinformatics tools to manage and analyze complex biological information, supporting studies related to diseases, genetics, and biological resources. Collaboration between academic institutions and research organizations is helping strengthen computational research capabilities. The increasing importance of genomic science and data-driven research is creating additional opportunities for bioinformatics adoption, while continued development of research infrastructure can further support the country's life sciences ecosystem.
List of Key and Emerging Players in Bioinformatics Market
Accelrys, Inc.
Affymetrix, Inc.
Agilent Technologies, Inc.
Geneva Bioinformatics
SA Nonlinear Dynamics
Quest Diagnostics, Inc.
Illumina
Bruker Daltonics Inc.
Biomax Informatics AG
Life Technologies Corporation
Sanofi
BioNTech
BioInvent
Juvenescence
Key Industry Developments
June 2026: Illumina expanded its bioinformatics portfolio with new cloud-based genomic data analysis capabilities, enabling researchers and clinical laboratories to accelerate next-generation sequencing workflows and improve genomic interpretation.
May 2026: NVIDIA expanded its collaboration with life science technology companies to advance AI-powered bioinformatics solutions, supporting accelerated genomic analysis, drug discovery, and precision medicine applications.
March 2026: Thermo Fisher Scientific expanded its Ion Torrent bioinformatics ecosystem with enhanced data analysis tools designed to improve genomic interpretation, variant detection, and clinical research workflows.
January 2026: Qiagen expanded its bioinformatics solutions portfolio with new digital analysis platforms and genomic interpretation tools supporting molecular diagnostics, research, and personalized healthcare applications.
Report Scope
Comments
No comment